3D-Side
TCD Capital advised 3D-side, a company active at the crossroads of the patient specific protheses and the software, for a capital increase of €3.000.000. 3D-Side is a software company with direct applications in Medical 3D Imaging and 3D Printing. It provides the market with an interesting development addressing the “missing link” between the practitioners and the […]
UniverCells
TCD Capital advised UniverCells for its fundraising of 17m of which 3 millions from Belgian Investors. Univercells is a medical engineering company whose aim is of addressing the vaccines and biologicals markets by providing fast and cheap production through delocalized smaller production units. Based on solid Intellectual Property and proven processes, it benefits of the […]